Sign Up | Log In | What is SocialPicks?

Investment Ideas Served Daily By People You Trust

SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.

Are you a stock guru?

Share picks & earn reputation

Eivind Hjermstad-Sollerud

Start Tracking Eivind Hjermstad-Sollerud - Add to Friends - Send Message

Community Rank: Analyst (114 pts) | Member since 12/30/2007

Picks Performance:

N/A

No percentile ranking
has been calculated.

What's this?

All-time Return -23.80% (in 1 year)	Risk (SD) Moderate 0.00%	Sharpe Ratio -12.8
Followers 0	Winning Picks 0 of 3	Total Views 737

Overview

Stocks

Stats

Community

Widget

Last Activity: Added QCOR to bullish list on 12/30/07

Current Stock List:

Symbol	SP Sentiment	Rating	Return	Since
QCOR			-26.72%	12/30/07
FRO			-44.67%	12/30/07

All-time Sectors of Interest

... View All >

Discussions

Eivind Hjermstad-Sollerud hasn't participated in any discussions yet.

People Following Eivind Hjermstad-Sollerud ...

Nobody is following Eivind Hjermstad-Sollerud.

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	381
2	Gerald Greene	18.14	+72.34%	210
3	stockmarketfunding.com	17.66	+25.65%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+76.91%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
KO	The CocaCola Company
WMT	WalMart Stores Inc
V	Visa Inc
BAC	Bank of America Corp
RIO	Companhia Vale Do Rio Doce
DRYS	DryShips Inc.

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla

... more »

Similarity to Me ?

Compare Your Portfolio With Eivind Hjermstad-Sollerud: Enter stocks you like & track your performance:

Symbols, separated by space (e.g. AAPL GOOG MSFT)

More about Eivind Hjermstad-Sollerud

Investment Style:
Moderate [?]

Avg exp holding time:
465.33 days

Age: below 20's	Occupation: Student
Location: Norway

Similar Portfolios

Marian Filo (supratrade) 62% 100%

supratrader (supratrader) N/A 100%

falanke (falanke) N/A 50%

sax (sax) N/A 50%

Yorgos Voyiatzis (voyiatzis) 42% 50%

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.